The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Nanoparticle-based targeted therapy through EGFR tyrosine kinase inhibitors and their recent advances in lung cancer therapy”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Dipanjan Karati, Soumi Das, Sreemoyee Mitra. Peptide-Based Drugs: Emerging Treatment Strategies of Lung Cancer by Overcoming Chemoresistance, International Journal of Peptide Research and Therapeutics. 2025; 31: 103. https://doi.org/10.1007/s10989-025-10767-2 |
|
2 |
2025 |
Zainab Sabri Abbas, Zaizafoon N. Nasif, Amer T. Tawfeeq. Osimertinib-Loaded Lactoferrin Nanoparticles for Lung Cancer Therapy, BioNanoScience. 2025; 15: 531. https://doi.org/10.1007/s12668-025-02166-0 |
|
3 |
2025 |
Dexin Xu, Wenbin Zhang, Yinping Pan, Wenhai Wang, Dongna Wang, Jian Ding. Progress in Nanocarriers‐Based Approaches for the Delivery of Tyrosine Kinase Inhibitors in Bone Cancer: Trends and Prospects, IUBMB Life. 2025; 77: e70052. https://doi.org/10.1002/iub.70052 |
|
4 |
2024 |
Surekha Ramachandran, Oral cancer: Recent breakthroughs in pathology and therapeutic approaches, Oral Oncology Reports. 2024; 12: 100678100678. https://doi.org/10.1016/j.oor.2024.100678 |
|
5 |
2025 |
Antónia Kurillová, Libor Kvítek, Aleš Panáček. Innovative Approaches in Cancer Treatment: Emphasizing the Role of Nanomaterials in Tyrosine Kinase Inhibition, Pharmaceutics. 2025; 17: 783. https://doi.org/10.3390/pharmaceutics17060783 |
|
6 |
2026 |
Cristian Cojocaru, Adina Magdalena Țurcanu, Ruxandra Cojocaru, Elena Cojocaru. Nanotechnology-Enabled Precision Therapy for Lung Cancer in Never-Smokers, Pharmaceutics. 2026; 18: 161. https://doi.org/10.3390/pharmaceutics18020161 |
|
7 |
2026 |
Merve Geyik, Gozde Bebek, Melek Nur Bilal, Burcu Nacak, Tugce Temel, Tuba Recber, Selma Sahin, Levent Oner, Emirhan Nemutlu, Gunes Esendagli, Suleyman Can Ozturk, Tugba Gulsun, Yagmur Akdag. Inhalable lyophilized dry powder of tumor-targeted gefitinib-loaded albumin nanoparticles for non small cell lung cancer treatment, Journal of Drug Delivery Science and Technology. 2026; 121: 108299108299. https://doi.org/10.1016/j.jddst.2026.108299 |